UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13
OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date
of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State
or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS
Employer Identification No.) |
|
| (Address of principal executive offices, including zip code) |
Registrant’s telephone
number, including area code: (
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name
of each exchange on which registered | ||
| The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 1.01 | Entry into a Material Definitive Agreement. |
On March 31, 2023, iSpecimen Inc. (the “Company”) entered into a Second Amendment to the First Amended and Restated Executive Employment Agreement with Tracy Curley, the Chief Executive Officer, Chief Financial Officer and Treasurer of the Company (the “Second Amendment”). A prior amendment to the First Amended and Restated Executive Employment Agreement was entered by and between the Company and Ms. Curley on January 24, 2023 solely to correct a clerical error in the vesting dates of certain equity awards and was deemed immaterial (the “First Amendment”).
Pursuant to the Second Amendment, the Company shall use its reasonable best efforts to nominate Ms. Curley to serve as a member of the Board of Directors of the Company (the “Board”) for so long as she is employed as the Chief Executive Officer of the Company and no additional compensation will be made to Ms. Curley for her service as a member of the Board. In addition, in the event that Ms. Curley’s employment as Chief Executive Officer is terminated or she resigns or becomes unaffiliated with the Company, Ms. Curley shall tender her resignation from the Board unless otherwise agreed upon by both parties.
The foregoing descriptions of the terms of the First Amendment and Second Amendment are qualified in their entirety by reference to the provisions of the First Amendment and Second Amendment filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K, which are incorporated by reference herein.
| Item 9.01. | Financial Statements and Exhibits. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 31, 2023
| iSPECIMEN INC. | ||
| By: | /s/ Tracy Curley | |
| Name: Tracy Curley | ||
| Title: Chief Executive Officer | ||